Sunmax Biotechnology Co Stock Price To Book
| 4728 Stock | TWD 278.50 0.50 0.18% |
Sunmax Biotechnology Co fundamentals help investors to digest information that contributes to Sunmax Biotechnology's financial success or failures. It also enables traders to predict the movement of Sunmax Stock. The fundamental analysis module provides a way to measure Sunmax Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sunmax Biotechnology stock.
Sunmax |
Sunmax Biotechnology Co Company Price To Book Analysis
Sunmax Biotechnology's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Sunmax Biotechnology Price To Book | 7.26 X |
Most of Sunmax Biotechnology's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sunmax Biotechnology Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Sunmax Biotechnology Co has a Price To Book of 7.2595 times. This is 71.73% lower than that of the Healthcare sector and 20.19% higher than that of the Biotechnology industry. The price to book for all Taiwan stocks is 23.66% higher than that of the company.
Sunmax Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sunmax Biotechnology's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sunmax Biotechnology could also be used in its relative valuation, which is a method of valuing Sunmax Biotechnology by comparing valuation metrics of similar companies.Sunmax Biotechnology is currently under evaluation in price to book category among its peers.
Sunmax Fundamentals
| Return On Equity | 0.48 | |||
| Return On Asset | 0.28 | |||
| Profit Margin | 0.39 % | |||
| Operating Margin | 0.56 % | |||
| Current Valuation | 8.1 B | |||
| Shares Outstanding | 54.46 M | |||
| Shares Owned By Insiders | 41.47 % | |||
| Shares Owned By Institutions | 9.24 % | |||
| Price To Book | 7.26 X | |||
| Price To Sales | 5.86 X | |||
| Revenue | 1.04 B | |||
| Gross Profit | 894.45 M | |||
| EBITDA | 416.06 M | |||
| Net Income | 245.64 M | |||
| Book Value Per Share | 22.04 X | |||
| Cash Flow From Operations | 243.28 M | |||
| Earnings Per Share | 9.24 X | |||
| Number Of Employees | 22 | |||
| Beta | 0.31 | |||
| Market Capitalization | 7.19 B | |||
| Total Asset | 1.48 B | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 1.48 B | |||
| Last Dividend Paid | 4.4 |
About Sunmax Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sunmax Biotechnology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sunmax Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sunmax Biotechnology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Sunmax Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sunmax Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunmax Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Sunmax Stock
| 0.59 | 2881B | Fubon Financial Holding | PairCorr |
| 0.5 | 2882 | Cathay Financial Holding | PairCorr |
| 0.46 | 2882A | Cathay Financial Holding Earnings Call Tomorrow | PairCorr |
| 0.33 | 2330 | Taiwan Semiconductor | PairCorr |
The ability to find closely correlated positions to Sunmax Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sunmax Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sunmax Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sunmax Biotechnology Co to buy it.
The correlation of Sunmax Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sunmax Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sunmax Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sunmax Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Sunmax Stock Analysis
When running Sunmax Biotechnology's price analysis, check to measure Sunmax Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunmax Biotechnology is operating at the current time. Most of Sunmax Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sunmax Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunmax Biotechnology's price. Additionally, you may evaluate how the addition of Sunmax Biotechnology to your portfolios can decrease your overall portfolio volatility.